Zogenix, Inc.
ZGNX
ZGNX was delisted on the 4th of March, 2022.
0 hedge funds and large institutions have $0 invested in Zogenix, Inc. in 2022 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 154 closing their positions.
100% less funds holding
Funds holding: 156 → 0 (-156)
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
100% less capital invested
Capital invested by funds: $968M → $0 (-$968M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 154
Top Buyers
Top Sellers
| 1 |
BlackRock
New York
|
-$93.2M |
| 2 |
CCM
Cadian Capital Management
New York
|
-$66.5M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$64.3M |
| 4 |
Morgan Stanley
New York
|
-$59.1M |
| 5 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$54.2M |
ZGNX Hedge Fund Activity: Q1 2022 in Review
0 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Zogenix, Inc. (ZGNX) for Q1 2022, worth a combined $0 — down 100% from $968M a quarter earlier.
Sellers outnumbered buyers: 154 funds closed out of ZGNX and 0 opened new positions — a net loss of 154 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was BlackRock, exiting entirely with an estimated $93.2M sold.
- 0 institutional investors held Zogenix, Inc. (ZGNX) as of Q1 2022, down from 156 in Q4 2021.
- Funds reported $0 of Zogenix, Inc. stock for Q1 2022, down 100% quarter-over-quarter.
- 0 funds opened new Zogenix, Inc. positions in Q1 2022 and 154 closed out, a net change of -154 holders.
- The largest Zogenix, Inc. seller in Q1 2022 was BlackRock, an estimated $93.2M sold.
Based on aggregated 13F filings for Q1 2022.